Cargando…

TGF-β induced reprogramming and drug resistance in triple-negative breast cells

BACKGROUND: The development of drug resistance remains to be a major cause of therapeutic failure in breast cancer patients. How drug-sensitive cells first evade drug inhibition to proliferate remains to be fully investigated. METHODS: Here we characterized the early transcriptional evolution in res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Guoyu, Li, Yuchao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994282/ https://www.ncbi.nlm.nih.gov/pubmed/35395809 http://dx.doi.org/10.1186/s40360-022-00561-x

Ejemplares similares

Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020)

Metabolic reprogramming in triple-negative breast cancer
por: Wang, Zhanyu, et al.
Publicado: (2020)

TGF-β-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel
por: Wardhani, Bantari WK, et al.
Publicado: (2020)

Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer
por: Tian, Jun, et al.
Publicado: (2017)

Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling
por: Vishnubalaji, Radhakrishnan, et al.
Publicado: (2021)

Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer
por: Suriyamurthy, Sudha, et al.
Publicado: (2019)

Triple-Negative Breast Cancer Cells Recruit Neutrophils by Secreting TGF-β and CXCR2 Ligands
por: SenGupta, Shuvasree, et al.
Publicado: (2021)

Hexokinase 2 Is a Pivot for Lovastatin-induced Glycolysis-to-Autophagy Reprogramming in Triple-Negative Breast Cancer Cells
por: Xue, Lian, et al.
Publicado: (2022)

Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-β-induced epithelial–mesenchymal transition via directly targeting TGFβR1
por: Zhang, Jingnan, et al.
Publicado: (2023)

4543 Glucocorticoid Receptors are essential effectors of TGFβ signaling in Triple Negative Breast Cancer
por: Kerkvliet, Carlos Jesus Perez, et al.
Publicado: (2020)

TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression
por: López-Tejada, Araceli, et al.
Publicado: (2023)

Pirfenidone suppressed triple‐negative breast cancer metastasis by inhibiting the activity of the TGF‐β/SMAD pathway
por: Luo, Daiqin, et al.
Publicado: (2023)

Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance
por: Jalalirad, Mohammad, et al.
Publicado: (2021)

Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer
por: Iorio, Egidio, et al.
Publicado: (2016)

MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer
por: Goode, Gennifer, et al.
Publicado: (2017)

Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Munkácsy, Gyöngyi, et al.
Publicado: (2023)

DGKZ promotes TGFβ signaling pathway and metastasis in triple-negative breast cancer by suppressing lipid raft-dependent endocytosis of TGFβR2
por: Zhao, Yuanyuan, et al.
Publicado: (2022)

TGF-β/activin signaling promotes CDK7 inhibitor resistance in triple-negative breast cancer cells through upregulation of multidrug transporters
por: Webb, Bryan M., et al.
Publicado: (2021)

Significance of combined TGF-β1 and survivin expression on the prognosis of patients with triple-negative breast cancer
por: Liu, Nannan, et al.
Publicado: (2022)

SRGN-TGFβ2 regulatory loop confers invasion and metastasis in triple-negative breast cancer
por: Zhang, Z, et al.
Publicado: (2017)

Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling
por: Jiang, Hong-Lin, et al.
Publicado: (2015)

GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer
por: Wei, Jin-Li, et al.
Publicado: (2021)

Inhibition of 6-Phosphogluconate Dehydrogenase Reverses Epirubicin Resistance Through Metabolic Reprograming in Triple-Negative Breast Cancer Cells
por: Xu, Jiali, et al.
Publicado: (2023)

Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer
por: Goode, Gennifer, et al.
Publicado: (2017)

TMEM158 Regulates the Canonical and Non-Canonical Pathways of TGF-β to Mediate EMT in Triple-Negative Breast Cancer
por: Tong, Jiaci, et al.
Publicado: (2022)

HTR1A Inhibits the Progression of Triple‐Negative Breast Cancer via TGF‐β Canonical and Noncanonical Pathways
por: Liu, Qiqi, et al.
Publicado: (2022)

A plasma protein derived TGFβ signature is a prognostic indicator in triple negative breast cancer
por: Katayama, Hiroyuki, et al.
Publicado: (2019)

ICAM1 promotes bone metastasis via integrin‐mediated TGF‐β/EMT signaling in triple‐negative breast cancer
por: Chen, Mingcang, et al.
Publicado: (2022)

Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway
por: Kim, Sangmin, et al.
Publicado: (2015)

Anti‐pyroptotic function of TGF‐β is suppressed by a synthetic dsRNA analogue in triple negative breast cancer cells
por: Tamura, Yusuke, et al.
Publicado: (2021)

DCST1-AS1 Promotes TGF-β-Induced Epithelial–Mesenchymal Transition and Enhances Chemoresistance in Triple-Negative Breast Cancer Cells via ANXA1
por: Tang, Li, et al.
Publicado: (2020)

Triple-negative breast cancer: understanding Wnt signaling in drug resistance
por: Merikhian, Parnaz, et al.
Publicado: (2021)

SHOC2 mediates the drug-resistance of triple-negative breast cancer cells to everolimus
por: Geng, Wenwen, et al.
Publicado: (2023)

Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer
por: Tan, Zheqiong, et al.
Publicado: (2023)

EGR1 and RXRA transcription factors link TGF-β pathway and CCL2 expression in triple negative breast cancer cells
por: Gorbacheva, Alisa M., et al.
Publicado: (2021)

Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer
por: Yi, Ming, et al.
Publicado: (2022)

Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition
por: Jiang, Lei, et al.
Publicado: (2014)

TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer
por: Hua, Wan, et al.
Publicado: (2019)

Mesenchymal Stem Cell-Induced Doxorubicin Resistance in Triple Negative Breast Cancer
por: Chen, Dar-Ren, et al.
Publicado: (2014)

TGFβ limits Myc-dependent TCR-induced metabolic reprogramming in CD8(+) T cells
por: Hope, Helen Carrasco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d9p8nauabr4kfbij8vdg8u7klb